Literature DB >> 36018533

Deep Learning Classification of Treatment Response in Diabetic Painful Neuropathy: A Combined Machine Learning and Magnetic Resonance Neuroimaging Methodological Study.

Kevin Teh1, Paul Armitage2, Solomon Tesfaye3, Dinesh Selvarajah3,4.   

Abstract

Functional magnetic resonance imaging (fMRI) has been shown successfully to assess and stratify patients with painful diabetic peripheral neuropathy (pDPN). This supports the idea of using neuroimaging as a mechanism-based technique to individualise therapy for patients with painful DPN. The aim of this study was to use deep learning to predict treatment response in patients with pDPN using resting state functional imaging (rs-fMRI). We divided 43 painful pDPN patients into responders and non-responders to lidocaine treatment (responders n = 29 and non-responders n = 14). We used rs-fMRI to extract functional connectivity features, using group independent component analysis (gICA), and performed automated treatment response deep learning classification with three-dimensional convolutional neural networks (3D-CNN). Using gICA we achieved an area under the receiver operating characteristic curve (AUC) of 96.60% and F1-Score of 95% in a ten-fold cross validation (CV) experiment using our described 3D-CNN algorithm. To our knowledge, this is the first study utilising deep learning methods to classify treatment response in pDPN.
© 2022. The Author(s).

Entities:  

Keywords:  Convolutional neural network; Functional magnetic resonance imaging; Painful diabetic peripheral neuropathy; Resting state; Treatment response

Year:  2022        PMID: 36018533     DOI: 10.1007/s12021-022-09603-5

Source DB:  PubMed          Journal:  Neuroinformatics        ISSN: 1539-2791


  1 in total

1.  Tracking Pain in Resting State Networks in Patients with Hereditary and Diabetic Neuropathy.

Authors:  Aslıhan Taşkiran Sağ; Arzu Ceylan Has; Neşe Öztekin; Çağrı Mesut Temuçin; Kader Karli Oğuz
Journal:  Noro Psikiyatr Ars       Date:  2018-07-09       Impact factor: 1.339

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.